Erasca reported favorable safety and tolerability with no dose-limiting toxicities and predominantly low-grade adverse events across all dose levels. Initial Phase 1 monotherapy data for ERAS-0015 are ...

Oncolytics also recently expanded its Scientific Advisory Board with globally recognized experts from Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center, positioning the company for ...

VANCOUVER, BC / ACCESS Newswire / January 14, 2026 / Future Fuels Inc. (TSXV:FTUR)(FSE:S0J)(OTCQX:FTURF) ("Future Fuels" or the "Company") is pleased to announce the results of its 2025 ground gravity ...

Detailed price information for Surge Copper Corp (SURG-X) from The Globe and Mail including charting and trades.

BRISBANE, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at ...

Sun Point requires live observation, outcomes tracking, and systemic supervision for every therapist—because clients deserve accountability. Gatekeeping is what sets Sun Point apart. Every clinical ...

ACNP abstracts are available on the conference website and the Company’s poster will be available on the Centessa website at https://investors.centessa.com/events-presentations after the poster ...

Detailed price information for American Tungsten Corp (TUNG-CN) from The Globe and Mail including charting and trades.

Premier American Uranium Inc. ("PUR", the "Company" or "Premier American Uranium"- (TSXV: PUR) (OTCQB: PAUIF) is pleased to ...

Schools located across Shah Alam, Klang and Bangi receive funding for infrastructure and equipment upgrades, financial aid, ...

Positive interim efficacy data in 2025 underscore potential of ETX101 as a one-time, disease-modifying medicine for Dravet syndrome –– Internal GMP manufacturing capable of supporting pivotal trial ...